Kehan Song

1.4k total citations · 1 hit paper
35 papers, 901 citations indexed

About

Kehan Song is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kehan Song has authored 35 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Kehan Song's work include Sarcoma Diagnosis and Treatment (12 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Musculoskeletal synovial abnormalities and treatments (5 papers). Kehan Song is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Musculoskeletal synovial abnormalities and treatments (5 papers). Kehan Song collaborates with scholars based in China, United States and France. Kehan Song's co-authors include Feng Li, Honglei Kang, Yimin Dong, Kai‐Yuan Lin, Meipeng Zhu, Renpeng Peng, Xiaosheng Ma, Hanfeng Guan, Yayun Zhang and Dawei Ye and has published in prestigious journals such as Cell Metabolism, Cancer and The FASEB Journal.

In The Last Decade

Kehan Song

34 papers receiving 894 citations

Hit Papers

A clinical-stage Nrf2 act... 2024 2026 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kehan Song China 18 295 235 209 182 156 35 901
Chan Hong Jeon South Korea 19 144 0.5× 203 0.9× 194 0.9× 361 2.0× 105 0.7× 59 1.0k
Jung Woo Lee South Korea 19 216 0.7× 154 0.7× 321 1.5× 91 0.5× 68 0.4× 94 1.2k
Toshihiro Matsuo Japan 20 213 0.7× 254 1.1× 360 1.7× 158 0.9× 103 0.7× 70 1.1k
Guodong Wang China 17 148 0.5× 125 0.5× 468 2.2× 75 0.4× 178 1.1× 75 957
Kenichiro Kusano Japan 14 513 1.7× 205 0.9× 221 1.1× 215 1.2× 387 2.5× 20 1.8k
Wenwei Qian China 22 268 0.9× 113 0.5× 904 4.3× 190 1.0× 82 0.5× 94 1.5k
Lene Bæksgaard Denmark 14 133 0.5× 336 1.4× 264 1.3× 84 0.5× 92 0.6× 40 864
Lili Ma China 21 276 0.9× 663 2.8× 623 3.0× 246 1.4× 122 0.8× 109 1.8k
Carlo Ruosi Italy 17 114 0.4× 81 0.3× 249 1.2× 100 0.5× 62 0.4× 40 779
Kamran Harati Germany 18 156 0.5× 398 1.7× 382 1.8× 144 0.8× 100 0.6× 73 1.0k

Countries citing papers authored by Kehan Song

Since Specialization
Citations

This map shows the geographic impact of Kehan Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kehan Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kehan Song more than expected).

Fields of papers citing papers by Kehan Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kehan Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kehan Song. The network helps show where Kehan Song may publish in the future.

Co-authorship network of co-authors of Kehan Song

This figure shows the co-authorship network connecting the top 25 collaborators of Kehan Song. A scholar is included among the top collaborators of Kehan Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kehan Song. Kehan Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Kehan, Zimeng Li, Zhiyan Liu, et al.. (2025). Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer. JAMA Otolaryngology–Head & Neck Surgery. 151(8). 761–761. 1 indexed citations
2.
Peng, Renpeng, Yimin Dong, Meng Zheng, et al.. (2024). IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. Cell Death and Disease. 15(2). 111–111. 20 indexed citations
4.
Dong, Yimin, Honglei Kang, Renpeng Peng, et al.. (2024). A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis. Cell Metabolism. 36(8). 1679–1695.e6. 48 indexed citations breakdown →
5.
Li, Guanghui, et al.. (2023). Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence. Osteoporosis International. 35(4). 659–668. 2 indexed citations
6.
Dong, Yimin, Yayun Zhang, Kehan Song, et al.. (2022). What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019. Clinical Orthopaedics and Related Research. 481(6). 1209–1220. 68 indexed citations
7.
Dong, Yimin, Kehan Song, Pengju Wang, et al.. (2022). Blocking the cytohesin-2/ARF1 axis by SecinH3 ameliorates osteoclast-induced bone loss via attenuating JNK-mediated IRE1 endoribonuclease activity. Pharmacological Research. 185. 106513–106513. 12 indexed citations
8.
Chen, Ying, et al.. (2022). Impact of Limb Salvage on Prognosis of Patients Diagnosed With Extremity Bone and Soft Tissue Sarcomas. Frontiers in Oncology. 12. 873323–873323. 5 indexed citations
9.
Kang, Honglei, Yimin Dong, Renpeng Peng, et al.. (2022). Inhibition of IRE1 suppresses the catabolic effect of IL-1β on nucleus pulposus cell and prevents intervertebral disc degeneration in vivo. Biochemical Pharmacology. 197. 114932–114932. 25 indexed citations
10.
Dong, Yimin, Linka Xie, Honglei Kang, et al.. (2021). A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma. Spine. 46(22). E1192–E1201. 4 indexed citations
11.
Dong, Yimin, Renpeng Peng, Honglei Kang, et al.. (2021). Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019. The Spine Journal. 22(5). 857–868. 72 indexed citations
12.
Chen, Ying, Honglei Kang, Kehan Song, et al.. (2021). Characteristics, incidence, and risk factors for death from fatal pneumonia among patients with primary malignant bone tumors: a SEER-based observational study. Translational Cancer Research. 10(8). 3659–3670. 7 indexed citations
13.
Song, Jian, Chaojun Zheng, Kehan Song, et al.. (2020). Exosome-Transported circRNA_0000253 Competitively Adsorbs MicroRNA-141-5p and Increases IDD. Molecular Therapy — Nucleic Acids. 21. 1087–1099. 56 indexed citations
14.
Jian, Chongshu, Jiajun Fu, Xu Cheng, et al.. (2020). Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis. Cell Metabolism. 31(5). 892–908.e11. 133 indexed citations
15.
Song, Kehan, et al.. (2019). Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study. International Orthopaedics. 43(8). 1983–1991. 33 indexed citations
16.
Song, Kehan, et al.. (2019). Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?. Clinical Orthopaedics and Related Research. 477(3). 573–583. 26 indexed citations
17.
Song, Kehan, Xiao Shi, Hongli Wang, et al.. (2018). Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study. International Orthopaedics. 42(12). 2941–2948. 22 indexed citations
18.
Song, Kehan, Xiao Shi, Hongli Wang, et al.. (2018). Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?. Clinical Orthopaedics and Related Research. 476(5). 987–996. 45 indexed citations
20.
Oshima, A, Aya Hanai, Isaburo Fujimoto, & Kehan Song. (1982). Cancer mortality among Koreans in Osaka, Japan.. PubMed. 62. 13–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026